A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface-Reference-Cited by-同舟云学术

A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface

Published:2016-01-06 Issue:1 Volume:14 Page:e1002344
ISSN:1545-7885
Container-title:PLOS Biology
language:en
Short-container-title:PLoS Biol

Author:

de Jong Rob N.,Beurskens Frank J.,Verploegen Sandra,Strumane Kristin,van Kampen Muriel D.,Voorhorst Marleen,Horstman Wendy,Engelberts Patrick J.,Oostindie Simone C.,Wang Guanbo,Heck Albert J. R.,Schuurman Janine,Parren Paul W. H. I.

Publisher

Public Library of Science (PLoS)

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference44 articles.

1. Complement is activated by IgG hexamers assembled at the cell surface;CA Diebolder;Science,2014

2. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics;JP Melis;Mol Immunol,2015

3. Engineered antibody Fc variants with enhanced effector function;GA Lazar;Proc Natl Acad Sci U S A,2006

4. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells;JO Richards;Mol Cancer Ther,2008

5. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R;RL Shields;J Biol Chem,2001

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies;Immunological Reviews;2024-09-14

2. Structural basis for surface activation of the classical complement cascade by the short pentraxin C-reactive protein;Proceedings of the National Academy of Sciences;2024-09-06

3. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas;International Journal of Molecular Sciences;2024-08-24

4. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab;International Journal of Molecular Sciences;2024-08-01

5. CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies;OncoImmunology;2024-06-04